Serum proteomic analysis identifies a highly sensitive and specific discriminatory pattern in stage 1 breast cancer

Background Mass spectrometry (MS)-based profiling was used to determine whether ion fingerprints could distinguish women with stage 1 breast cancer from women without breast cancer.